US 12,213,951 B2
Treatment of autism with cannabidiol
Terri Sebree, Gladwyne, PA (US); Marcel Bonn-Miller, Lexington, NC (US); and Donna Gutterman, Raleigh, NC (US)
Assigned to Harmony Biosciences Management, Inc., Plymouth Meeting, PA (US)
Filed by Harmony Biosciences Management, Inc., Plymouth Meeting, PA (US)
Filed on Mar. 21, 2023, as Appl. No. 18/124,460.
Application 18/124,460 is a continuation of application No. 17/465,141, filed on Sep. 2, 2021, abandoned.
Application 17/465,141 is a continuation of application No. 16/737,326, filed on Jan. 8, 2020, abandoned.
Application 16/737,326 is a continuation of application No. 16/411,248, filed on May 14, 2019, granted, now 10,568,848, issued on Feb. 25, 2020.
Application 16/411,248 is a continuation of application No. 16/220,249, filed on Dec. 14, 2018, granted, now 10,314,792, issued on Jun. 11, 2019.
Application 16/220,249 is a continuation of application No. 16/144,632, filed on Sep. 27, 2018, granted, now 10,213,390, issued on Feb. 26, 2019.
Claims priority of provisional application 62/632,532, filed on Feb. 20, 2018.
Claims priority of provisional application 62/564,834, filed on Sep. 28, 2017.
Prior Publication US 2023/0364028 A1, Nov. 16, 2023
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 31/05 (2006.01); A61K 9/00 (2006.01); A61K 9/06 (2006.01); A61K 36/185 (2006.01); A61P 25/00 (2006.01)
CPC A61K 31/05 (2013.01) [A61K 9/0014 (2013.01); A61K 9/06 (2013.01); A61K 36/185 (2013.01); A61P 25/00 (2018.01)] 8 Claims
 
1. A method of treating a human suffering from an autism spectrum disorder comprising:
transdermally administering via a gel or cream a therapeutically effective amount of purified cannabidiol to the human suffering from the autism spectrum disorder to effectively treat the autism spectrum disorder in the human in need thereof,
wherein the gel or cream is administered to the upper arm.